Tag: CytoSen Therapeutics
No posts to display
News
Gossamer Bio and Chiesi Group enter global collaboration to develop and commercialize seralutinib
Gossamer Bio, a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Group, an...
Sentynl Therapeutics acquires Zokinvy for treatment of Hutchinson-Gilford progeria syndrome
Sentynl Therapeutics, a US-based biopharmaceutical company wholly-owned by Zydus Lifesciences, has acquired Eiger BioPharmaceuticals' Zokinvy® (lonafarnib) program.
Zokinvy is the first and only treatment approved by...
Bayer and Evotec to develop precision treatments for cardiovascular diseases
Bayer and German-based life science company, Evotec, have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).
The...
